A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy Participants

NCT02752087 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY900014

Sponsor

Eli Lilly and Company